Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,758.80
-15.70 (-0.88%)
Jul 30, 2026, 3:30 PM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 450.2 billion as of July 30, 2026. Its market cap has increased by 19.21% in one year.
Market Cap
450.20B
Enterprise Value
460.93B
Revenue
96.47B
Ranking
n/a
PE Ratio
39.45
Stock Price
1,758.80
ChartMarket Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 450.20B, an increase of 13,886.74%. That is a compound annual growth rate of 22.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 446.21B | 23.96% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mankind Pharma | 1.05T |
| Aurobindo Pharma | 891.49B |
| Laurus Labs | 864.42B |
| Alkem Laboratories | 671.03B |
| Glenmark Pharmaceuticals | 618.58B |
| Ajanta Pharma | 420.81B |
| Gland Pharma | 392.09B |
| Emcure Pharmaceuticals | 364.92B |